Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation by HPLC.
An accurate, simple, reproducible, and sensitive HPLC method was developed and validated for the simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation. The analyses were performed on an RP C18 column, 150 x 4.60 mm id, 5 pm particle size. The mobile phase methanol-acetonitrile-water (76 + 13 + 11, v/v/v), was pumped at a constant flow rate of 1 mL/min. UV detection was performed at 253 nm. Retention times of atorvastatin calcium, ezetimibe, and fenofibrate were found to be 2.25, 3.68, and 6.41 min, respectively. The method was validated in terms of linearity, precision, accuracy, LOD, LOQ, and robustness. The response was linear in the range 2-10 microg/mL (r2 = 0.998) for atorvastatin calcium, 2-10 microg/mL (r2 = 0.998) for ezetimibe, and 40-120 microg/mL (r2 = 0.998) for fenofibrate. The developed method can be used for routine quality analysis of the drugs in the tablet formulation.
Kadi Sarva Vishwavidyalaya, Gandhinagar, Gujarat, India. architajpatel@gmail.com
Archita
A
Patel
Chhaya
C
Macwana
Vishal
V
Parmar
Samir
S
Patel
D000924:Anticholesteremic Agents / Q000737:chemistry; D000069059:Atorvastatin; D001384:Azetidines / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D000069438:Ezetimibe; D011345:Fenofibrate / Q000737:chemistry*; D006538:Heptanoic Acids / Q000737:chemistry*; D000960:Hypolipidemic Agents / Q000737:chemistry; D011758:Pyrroles / Q000737:chemistry*; D013607:Tablets / Q000737:chemistry
D000924:Anticholesteremic Agents; D001384:Azetidines; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D013607:Tablets; D000069059:Atorvastatin; D000069438:Ezetimibe; D011345:Fenofibrate